mocetinostat
Showing 1 - 6 of 6
Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)
Recruiting
- Rhabdomyosarcoma
- Vinorelbine
- Mocetinostat
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 13, 2022
Lymphoma, Relapsed and Refractory, DLBCL and Follicular Lymphoma Trial in New York (Mocetinostat)
Active, not recruiting
- Lymphoma
- +2 more
- Mocetinostat
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Sep 17, 2021
Metastatic Leiomyosarcoma Trial in United States (Mocetinostat, Gemcitabine)
Completed
- Metastatic Leiomyosarcoma
- Mocetinostat
- Gemcitabine
-
Boston, Massachusetts
- +4 more
Jan 4, 2019
Squamous Cell Carcinoma, Head And Neck, Squamous Cell Carcinoma Mouth, Resectable Squamous Cell Carcinoma of Oral Cavity Trial
Withdrawn
- Squamous Cell Carcinoma, Head And Neck
- +2 more
- Mocetinostat
- Durvalumab
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Dec 27, 2017
Myelodysplastic Syndrome Trial in United States (Mocetinostat, Azacitidine)
Completed
- Myelodysplastic Syndrome
- Mocetinostat
- Azacitidine
-
Washington, D.C., District of Columbia
- +9 more
Sep 6, 2017
Urothelial Carcinoma Trial in United States (Mocetinostat)
Completed
- Urothelial Carcinoma
- Mocetinostat
-
Birmingham, Alabama
- +13 more
Aug 30, 2017